Assignee
SIWA CORP
US·21 granted patents·11 pending applications·182 citations·filing 2015–2024
Top patents by PatentIndex Score
32 records- 0198US11542324B2Humanized monoclonal advanced glycation end-product antibodySIWA CORP·Filed 2020·Granted Jan 3, 2023·6 cites·14 claims
- 0297US10919957B2Humanized monoclonal advanced glycation end-product antibodySIWA CORP·Filed 2018·Granted Feb 16, 2021·11 cites·26 claims
- 0397US9993535B2Method and composition for treating sarcopeniaSIWA CORP·Filed 2015·Granted Jun 12, 2018·19 cites·20 claims
- 0496US10995151B1Methods and compositions for treating disease-related cachexiaSIWA CORP·Filed 2018·Granted May 4, 2021·10 cites·20 claims
- 0596US10960234B2Selective removal of cells having accumulated agentsSIWA CORP·Filed 2015·Granted Mar 30, 2021·11 cites·12 claims
- 0696US10858449B1Methods and compositions for treating osteoarthritisSIWA CORP·Filed 2018·Granted Dec 8, 2020·13 cites·20 claims
- 0796US10358502B2Product and method for treating sarcopeniaSIWA CORP·Filed 2015·Granted Jul 23, 2019·12 cites·14 claims
- 0896US10226531B2Selective removal of age-modified cells for treatment of atherosclerosisSIWA CORP·Filed 2017·Granted Mar 12, 2019·18 cites·28 claims
- 0995US11261241B2Methods, compositions and apparatuses for facilitating regenerationSIWA CORP·Filed 2017·Granted Mar 1, 2022·8 cites·20 claims
- 1095US10961321B1Methods and compositions for treating pain associated with inflammationSIWA CORP·Filed 2018·Granted Mar 30, 2021·10 cites·23 claims
- 1195US10889634B2Anti-age antibodies and methods of use thereofSIWA CORP·Filed 2016·Granted Jan 12, 2021·12 cites·26 claims
- 1295US10584180B2Anti-AGE antibodies for treating inflammation and auto-immune disordersSIWA CORP·Filed 2015·Granted Mar 10, 2020·19 cites·29 claims
- 1393US11518801B1Methods and compositions for treating diabetes and diabetic complicationsSIWA CORP·Filed 2018·Granted Dec 6, 2022·6 cites·20 claims
- 1491US11213585B2Vaccines for use in treating various diseases and disordersSIWA CORP·Filed 2016·Granted Jan 4, 2022·8 cites·18 claims
- 1589US11873345B2Product and method for treating sarcopeniaSIWA CORP·Filed 2019·Granted Jan 16, 2024·2 cites·20 claims
- 1688US11872269B2Method and composition for treating sarcopeniaSIWA CORP·Filed 2018·Granted Jan 16, 2024·2 cites·17 claims
- 1788US10925937B1Vaccines for use in treating juvenile disorders associated with inflammationSIWA CORP·Filed 2018·Granted Feb 23, 2021·10 cites·22 claims
- 1887US11958900B2Anti-age antibodies for treating neurodegenerative disordersSIWA CORP·Filed 2017·Granted Apr 16, 2024·2 cites·20 claims
- 1985US11833202B2Method and composition for treating cancer, killing metastatic cancer cells and preventing cancer metastasis using antibody to advanced glycation end products (AGE)SIWA CORP·Filed 2017·Granted Dec 5, 2023·2 cites·13 claims
- 2084US12134660B2Anti-age antibodies for treating inflammation and auto-immune disordersSIWA CORP·Filed 2020·Granted Nov 5, 2024·1 cites·20 claims
- 2179US12226465B2Humanized monoclonal advanced glycation end-product antibodySIWA CORP·Filed 2022·Granted Feb 18, 2025·0 cites·14 claims
- 2276US2025250331A1Anti-age antibodies for treating neurodegenerative disordersSIWA CORP·Filed 2024·Application pending·0 cites
- 2373US2021236860A1Selective removal of cells having accumulated agentsSIWA CORP·Filed 2021·Application pending·0 cites
- 2465US2022160869A1Vaccines for use in treating various diseases and disordersSIWA CORP·Filed 2021·Application pending·0 cites
- 2564US2021253737A1Methods and compositions for treating disease-related cachexiaSIWA CORP·Filed 2021·Application pending·0 cites
- 2659US2019328876A1Selective removal of age-modified cells for treatment of atherosclerosisSIWA CORP·Filed 2019·Application pending·0 cites
- 2759US2024000930A1Methods and compositions for treating kidney diseasesSIWA CORP·Filed 2021·Application pending·0 cites
- 2859US2018111982A2Methods, compositions and apparatuses for facilitating regenerationSIWA CORP·Filed 2015·Application pending·0 cites
- 2957US2023181730A1Methods of treating infectionsSIWA CORP·Filed 2021·Application pending·0 cites
- 3054US2022175916A1Methods and compositions for treating chronic effects of radiation and chemical exposureSIWA CORP·Filed 2019·Application pending·0 cites
- 3149US2020150131A1Diagnostic advanced glycation end-product antibodiesSIWA CORP·Filed 2018·Application pending·0 cites
- 3246US2021253739A1Anticarboxymethyl lysine antibodies and ultrasound for removing age-modified cellsSIWA CORP·Filed 2019·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →